your limit has been reached. plz Donate us to allow your ip full access, Email: sshnevis@outlook.com
Uptodate Reference Title
Risk-adjusted survival after treatment decision for clinically staged (c), pathologically staged (p), and posttreatment pathologically staged (yp) adenocarcinoma of the esophagus and esophagogastric junction
Risk-adjusted survival after treatment decision for clinically staged (c), pathologically staged (p), and posttreatment pathologically staged (yp) adenocarcinoma of the esophagus and esophagogastric junction
(A) Risk-adjusted survival after treatment decision for clinically staged (c) adenocarcinoma of the esophagus based on WECC data. (B) Risk-adjusted survival after treatment decision for pathologically staged (p) adenocarcinoma of the esophagus based on WECC data. (C) Risk-adjusted survival after treatment decision for postneoadjuvant pathologically staged (yp) adenocarcinoma of the esophagus based on WECC data.
WECC: Worldwide Esophageal Cancer Collaboration.
Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing.
